Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(4 sites)

United States

Burke Pharmaceutical Research, Hot Springs, Arkansas

Minnesota Clinical Study Center, New Brighton, Minnesota

Schlessinger MD Skin Research Center, Omaha, Nebraska

Austin Institute for Clinical Research, Pflugerville, Texas